Castellon-Lopez Yelba, Duru O Kenrik, Turk Norman, Moreno Gerardo, Norris Keith C, Vu Amanda, Saju Rintu P, Tseng Chi-Hong, Skrine-Jeffers Kia, Mangione Carol M, Frosch Dominick, Moin Tannaz
Department of Biomedical Sciences, Cedars-Sinai Medical Center, Cancer Research Center for Health Equity, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, USA.
David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Health Equity. 2024 Aug 26;8(1):659-666. doi: 10.1089/heq.2023.0186. eCollection 2024.
To achieve health equity, interventions should yield similar effectiveness across all patient subgroups. However, the adoption of diabetes prevention strategies and successful weight loss in "real-world" Diabetes Prevention Program (DPP) translational studies have varied by race and ethnicity. We examined racial and ethnic differences in diabetes prevention outcomes among study participants from the Prediabetes Informed Decisions and Education (PRIDE) Study.
In a retrospective analysis of data from the PRIDE cluster randomized trial across a large health system, we examined (1) percent weight change and (2) uptake of DPP and/or metformin among overweight/obese participants with prediabetes 12 months after participating in a pharmacist-led shared decision-making (SDM) intervention. We stratified the outcomes by race and ethnicity using a generalized linear mixed-effects model.
The study participants ( = 515) had an average age of 56 years (standard deviation [SD] = 11.0), hemoglobin A1c of 6.0% (SD = 0.20), and body mass index of 30.3 (SD = 5.2). Black/African American and Latino study participants lost significantly less weight at the 12-month follow-up compared with White/Caucasian participants (-1.0% and -1.2%, respectively, vs. -3.3%, < 0.01 for both comparisons). There was no significant difference in the adoption of diabetes prevention strategies between racial and ethnic groups after completing an educational SDM intervention.
To better promote health equity, future studies should investigate the potential causal factors for these differences in weight loss, such as variations in socioeconomic status, physical activity, cultural influences, and neighborhood characteristics.
为实现健康公平,干预措施应在所有患者亚组中产生相似的效果。然而,在“现实世界”的糖尿病预防计划(DPP)转化研究中,糖尿病预防策略的采用情况以及成功减重情况因种族和民族而异。我们研究了糖尿病前期知情决策与教育(PRIDE)研究中参与者在糖尿病预防结果方面的种族和民族差异。
在一项对大型医疗系统中PRIDE整群随机试验数据的回顾性分析中,我们研究了(1)体重变化百分比,以及(2)在参与药剂师主导的共同决策(SDM)干预12个月后,糖尿病前期超重/肥胖参与者中DPP和/或二甲双胍的使用情况。我们使用广义线性混合效应模型按种族和民族对结果进行分层。
研究参与者(n = 515)的平均年龄为56岁(标准差[SD] = 11.0),糖化血红蛋白为6.0%(SD = 0.20),体重指数为30.3(SD = 5.2)。在12个月的随访中,黑人/非裔美国人和拉丁裔研究参与者的体重减轻明显少于白人/高加索参与者(分别为-1.0%和-1.2%,而白人/高加索参与者为-3.3%,两组比较P均<0.01)。在完成教育性SDM干预后,不同种族和民族群体在采用糖尿病预防策略方面没有显著差异。
为了更好地促进健康公平,未来的研究应调查这些体重减轻差异的潜在因果因素,如社会经济地位、身体活动、文化影响和社区特征的差异。